EUCTR2005-004730-41-IT进行中（未招募）不适用
A PHASE II, MULTI-CENTER STUDY OF MELPHALAN 100 mg/m2 (MEL 100) as transplant, REVLIMID and PREDNISONE (RP) as consolidation and REVLIMID ALONE as maintenance IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.
FONDAZIONE NEOPLASIE SANGUE ONLUS0 个研究点开始时间: 2007年11月7日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase II study evaluating intravenous Melphalan with autologous whole blood stem cell transplantation (PBSCT) in patients with Androgen –Independent Prostate Cancer (AIPC) - Melphalan in AIPC / Mel-CaPOpen-labelled, non-randomised, treatment intensifying cohort study in androgen-independent prostate cancer (AIPC.)EUCTR2006-002210-36-GBQueen Mary University of London
已完成
2 期
Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous TransplantationMultiple MyelomaNCT02669615Medical College of Wisconsin24
进行中（未招募）
1 期
A Single Arm Phase II Study to assess the efficacy of intensified intravenous Melphalan in combination with a transplant of the patient's own blood stem cells for a maximum of three cycles in patients with castration-resistant prostate cancer (CRPC)EUCTR2012-000351-14-GBBarts Health NHS Trust29
进行中（未招募）
1 期
A multicentre Phase II study with Alpharen™: an open-label, dose-ranging phase followed by a placebo-controlled, double-blind, parallel-group comparison in haemodialysis subjects with hyperphosphataemiaEUCTR2005-005746-39-GBIneos Healthcare Ltd160
已完成
2 期
Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma PatientsMultiple MyelomaNCT00358020University of Turin, Italy30